tradingkey.logo
tradingkey.logo
Buscar

Avalon Globocare Corp

ALBT
Añadir a la lista de seguimiento
0.282USD
-0.009-3.09%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
2.35MCap. mercado
PérdidaP/E TTM

Más Datos de Avalon Globocare Corp Compañía

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.

Información de Avalon Globocare Corp

Símbolo de cotizaciónALBT
Nombre de la empresaAvalon Globocare Corp
Fecha de salida a bolsaFeb 22, 2016
Director ejecutivoJin (David)
Número de empleados5
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 22
Dirección4400 Route 9
CiudadFREEHOLD
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07728
Teléfono17327804400
Sitio Webhttps://www.avalon-globocare.com/
Símbolo de cotizaciónALBT
Fecha de salida a bolsaFeb 22, 2016
Director ejecutivoJin (David)

Ejecutivos de Avalon Globocare Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--
Dr. The Hon. Tevi Troy, Ph.D.
Dr. The Hon. Tevi Troy, Ph.D.
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Avalon Globocare Corp?

Los cinco principales accionistas de Avalon Globocare Corp son: Mr. Wenzhao (Daniel) Lu

¿Cuántas instituciones poseen acciones de Avalon Globocare Corp (ALBT)?

A fecha de 2026Q1, 30 instituciones poseen acciones de Avalon Globocare Corp, con un valor de mercado combinado de aproximadamente 83.03K, lo que representa el 1.00% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -43859.00.